SHANK1 and non-small cell lung carcinoma: Base on abovementioned results, we found SHANK1 was obviously high-expressed in NSCLC especially in LUAD patients and closely related to tumor prognosis, we mainly focused on the role of SHANK1 in LUAD cells in our follow-up study.